J. Beaumont, Les arythmies cardiaques: un guide clinique et thérapeutique, Chenelière éducation, 2011.

P. Dorian, G. V. Naccarelli, P. Coumel, S. H. Hohnloser, and M. J. Maser, A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia, The American Journal of Cardiology, vol.77, issue.3, pp.89-9510, 1996.
DOI : 10.1016/S0002-9149(97)89123-0

S. S. Chugh, J. L. Blackshear, W. K. Shen, S. C. Hammill, and B. J. Gersh, Epidemiology and natural history of atrial fibrillation: clinical implications, Journal of the American College of Cardiology, vol.37, issue.2, pp.371-7811216949, 2001.
DOI : 10.1016/S0735-1097(00)01107-4

M. E. Silverman, From rebellious palpitations to the discovery of auricular fibrillation: Contributions of Mackenzie, Lewis and Einthoven, The American Journal of Cardiology, vol.73, issue.5, pp.384-8910, 1994.
DOI : 10.1016/0002-9149(94)90013-2

W. B. Kannel, P. A. Wolf, E. J. Benjamin, D. S. Levy, E. M. Go et al., Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available., Diévart, P. De Groote, pp.2-9, 1998.
DOI : 10.1016/S0002-9149(98)00583-9

J. Leenhardt, G. Pinel, J. Pisica-donose, and . Heuzey, Epidemiology of Atrial Fibrillation in France: Extrapolation of International Epidemiological Data to France and Analysis of French Hospitalization Data Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF Study, Arch. cardiovasc. dis. Am. heart j, vol.104, issue.14703, pp.115-139, 2004.

C. M. Tchou, C. W. Tracy, A. Yancy, and . Hrs, Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary How to Define Valvular Atrial Fibrillation?, J. Am. Coll. Cardiol. Arch. cardiovasc. dis, vol.64, issue.108, pp.2246-80, 2014.

M. Molteni, H. Polo-friz, L. Primitz, G. Marano, P. Boracchi et al., The Definition of Valvular and Non-Valvular Atrial Fibrillation: Results of a Physicians' Survey Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin The Management of Clinical Arrhythmias, Europace Circulation, vol.16, issue.110, pp.1720-1745, 2004.

I. Electrophysiology, . Eur, J. Heart, N. Saoudi, J. Deharo et al., Précis de Rythmologie, Sauramps Médical Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study, Circulation 98 PMID: 9737513 All-Cause Mortality in 272 186 Patients Hospitalized with Incident Atrial Fibrillation 1995-2008: A Swedish Nationwide Long-Term Case-Control Study Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study The Framingham Heart Study and the Epidemiology of Cardiovascular Disease: A Historical Perspective, The Lancet 383, 24 A. Arboix, M. C. Vericat, R. Pujades, J. Massons, L. García-Eroles and M. Oliveres, pp.92-99, 1987.

G. Baruffi, A. Landini, C. D. Ghetti, D. Wolfe, and . Inzitari, Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe : Data From a Multicenter Multinational Hospital-Based Registry (The European Community Stroke Project), Stroke, vol.32, pp.392-98, 2001.

S. M. Lai, M. Alter, G. Friday, E. A. Sobel, R. D. Wolf et al., A multifactorial analysis of risk factors for recurrence of ischemic stroke, Prevention of Stroke in Patients with Nonvalvular, pp.958-62, 1991.
DOI : 10.1161/01.STR.25.5.958

P. A. Howard, C. Knecht, T. Oelschlager, and H. Duning, Guidelines for Stroke Prevention in Patients with Atrial Fibrillation, Drugs, vol.58, issue.6, pp.997-1009, 1999.
DOI : 10.2165/00003495-199958060-00004

K. Breithardt, E. B. Berger, P. Ringelstein, H. Kirchhof, and . Wersching, Atrial Fibrillation in Stroke-Free Patients Is Associated with Memory Impairment and Hippocampal Atrophy

J. Kilander, B. Andrén, H. Nyman, L. Lind, M. Boberg et al., Atrial Fibrillation Is an Independent Determinant of Low Cognitive Function : A Cross-Sectional Study in Elderly Men, Stroke, vol.29, issue.9, pp.2125-2157, 1998.
DOI : 10.1161/01.STR.29.9.1816

J. Ball, M. J. Carrington, and S. Stewart, Mild Cognitive Impairment in High-Risk Patients with

M. O. Marzona, K. Donnell, P. Teo, C. Gao, J. Anderson et al., Atrial Fibrillation, Stroke and Dementia in the Very Old: A Population-Based Study Increased Risk of Cognitive and Functional Decline in Patients with Atrial Fibrillation: Results of the ONTARGET and TRANSCEND Studies, Chronic Atrial Fibrillation: A Forgotten Component of Clinical Management, pp.542-589, 2011.

. Ladwig, Depressed Mood Amplifies Heart-Related Symptoms in Persistent and Paroxysmal Atrial Fibrillation Patients: A Longitudinal Analysis-data from the German Competence Network on

A. S. Fibrillation, D. J. Thompson, S. F. Barksdale, J. P. Sears, I. Mounsey et al., The Effect of Anxiety and Depression on Symptoms Attributed to Atrial Fibrillation: DEPRESSION, Europace Pacing clin. electrophysiol, vol.17, issue.37, pp.1354-62, 2014.

P. M. Mahaffey and B. J. , Psychopathology and Symptoms of Atrial Fibrillation: Implications for Therapy, J. cardiovasc. electrophysiol, vol.23, pp.473-78, 2012.

E. Gersh, G. Hylek, A. S. Naccarelli, J. Go, P. Reiffel et al., Drivers of Hospitalization for Patients with Atrial Fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF), Am. heart j The Economic Burden of Ischemic Stroke and Major Hemorrhage in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation: A Retrospective Claims Analysis, PMID: 25126372. 41 Developed with the special contribution of the European Heart Rhythm Association (EHRA) A, pp.735-742, 2014.

J. Camm, P. Kirchhof, G. Y. Lip, U. Schotten, I. Savelieva et al., Guidelines for the Management of Atrial Fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur. heart j, pp.2369-2429, 2010.

D. J. Slotwiner, M. A. Scheiner, B. B. Lerman, K. Gitt, W. Smolka et al., Transthoracic Cardioversion of Atrial Fibrillation: Comparison of Rectilinear Biphasic versus Damped Sine Wave Monophasic Shocks Types and Outcomes of Cardioversion in Patients Admitted to Hospital for Atrial Fibrillation: Results of the German RHYTHM-AF Study, Circulation Clin. res. cardiol, vol.101, issue.102, pp.1282-87, 1007.

J. Hansen, L. Kober, S. Husted, C. E. Torp-pedersen, T. Airaksinen et al., Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy, EP Europace, vol.17, issue.1, pp.18-23, 2015.
DOI : 10.1093/europace/euu189

. Hartikainen, Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation, J

P. L. Mouroux, J. Métayer, and . Clémenty, Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins, New Engl. j. med, pp.659-66, 1998.

G. Anselme, P. Inama, and . Jais, The Atrial Fibrillation Ablation Pilot Study: An European Survey on Methodology and Results of Catheter Ablation for Atrial Fibrillation Conducted by the European Heart Rhythm Association Recent Advances in the Understanding and Management of Atrial Fibrillation: A Focus on Stroke Prevention Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach, Eur. heart j, vol.35, issue.137, pp.1466-78, 1378.

D. A. Lane and G. Y. Lip, Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation, Analysis of CHADS2 versus CHA2DS2 -VASc for, pp.860-65
DOI : 10.1161/CIRCULATIONAHA.111.060061

M. Coppens, J. W. Eikelboom, R. G. Hart, S. Yusuf, G. Y. Lip et al., The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy, European Heart Journal, vol.34, issue.3
DOI : 10.1093/eurheartj/ehs314

J. B. Olesen, C. Torp-pedersen, M. L. Hansen, and G. Y. Lip, The Value of the

T. S. Potpara, M. M. Polovina, M. M. Licina, J. M. Marinkovic, M. S. Prostran et al., Reliable Identification of "Truly Low" Thromboembolic Risk in Patients Initially Diagnosed With "Lone" Atrial Fibrillation: The Belgrade Atrial Fibrillation Study, Circulation: Arrhythmia and Electrophysiology, vol.5, issue.2, pp.319-345, 2012.
DOI : 10.1161/CIRCEP.111.966713

K. W. Mahaffey, P. Chang, G. C. Fonarow, M. J. Pencina, J. P. Piccini et al., The ORBIT Bleeding Score: A Simple Bedside Score to Assess Bleeding Risk in Atrial Fibrillation, Euro. heart j, 2015.

. Singer, The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and, J. Am. Coll. Cardiol, vol.58, pp.395-401, 2011.

E. R. Abumuaileq, S. Abu-assi, M. Raposeiras-roubin, C. Rodríguez-mañero, J. Peña-gil et al., Comparison Between 3 Bleeding Scoring Systems in Nonvalvular Atrial Fibrillation Patients. What Can the New ORBIT Score Provide?, Analysis: HAS-BLED for Predicting Bleeding Risk in AF 62 Developed with the special contribution of the European Heart Rhythm Association (EHRA) A, pp.555-61, 2015.
DOI : 10.1016/j.rec.2016.05.022

G. Attar, B. Hindricks, and . Prendergast, Guidelines for the Management of Atrial Fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of, Cardiology

. Wallentin, The Novel Biomarker-Based ABC (Age, Biomarkers, Clinical History)-Bleeding Risk Score for Patients with Atrial Fibrillation: A Derivation and Validation Study, The Lancet 387, pp.2302-1110

Y. Chang and B. Hellemons, Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation: An Individual Patient Meta-Analysis, 2002.

K. E. Pedersen, D. A. Lionetti, J. Stangier, L. J. Wallentin, and M. D. Connolly, Dabigatran With or Without Concomitant Aspirin Compared With Warfarin Alone in Patients With Nonvalvular Atrial Fibrillation (PETRO Study), Am. j. cardiol, vol.100, pp.1419-1445, 2007.

H. Darius, C. D. Diener, L. Joyner, and . Wallentin, Dabigatran versus Warfarin in Patients with

A. Fibrillation, N. J. Engl, L. Romanelli, M. Nolting, E. Dolginsky et al., Dabigatran versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta- Analysis, Circ., Cardiovasc. qual. outcomes, vol.361, issue.9, pp.1139-51, 2009.

A. A. Fox, R. M. Califf, R. The, . Af-steering, and . Committee, Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation, H. Lip, Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and, pp.883-91, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01038111

B. S. Weitz, A. Lewis, T. Parkhomenko, E. M. Yamashita, and . Antman, Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation
URL : https://hal.archives-ouvertes.fr/hal-00935589

D. Pugh, J. Pugh, and G. E. Mead, Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review, Age and Ageing, vol.40, issue.6, pp.675-83, 2011.
DOI : 10.1093/ageing/afr097

. Sievert, Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation, J. Am. Coll. Cardiol, vol.61, pp.2551-56, 2013.

N. C. Marzi, P. D. Sora, P. Bella, R. Mazzone, and J. Horton, Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target, BioMed Res. Int, pp.1-13, 2015.

R. Sanchez, S. Bai, and . Mohanty, Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation?, J. Am. Coll. Cardiol, vol.60, pp.531-569, 2012.

. Oshita, J. Chapeau, P. W. Gutkowska, R. W. Schiller, G. Milne et al., Localization of Immunoreactive Synthetic Atrial Natriuretic Factor (ANF) in the Heart of Various Animal Species The Effect of Distending the Atrial Appendages on Urine Flow in the Dog, Sanders, M. Rotter and M. HaïSsaguerre, Disconnection of the Left Atrial, pp.327-359, 1972.

J. L. Blackshear and J. A. Odell, Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation, The Annals of Thoracic Surgery, vol.61, issue.2, pp.755-5910, 1996.
DOI : 10.1016/0003-4975(95)00887-X

. Nonvalvular-atrial-fibrillation, The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography, Ann. intern. medicin, vol.128, pp.639-686, 1998.

W. D. Johnson, A. K. Ganjoo, C. D. Stone, R. C. Srivyas, and M. Howard, The Left Atrial

. Surg, K. P. Su, S. Y. Mccarthy, and . Ho, Occluding the Left Atrial Appendage: Anatomical Considerations, Elimination of the Left Atrial Appendage to Prevent Stroke or Embolism? Anatomic, Physiologic, and Pathophysiologic Considerations, pp.718-740, 2000.

C. Abouzahr, S. Sawchuck, C. Carroll, P. Morillo, V. Kleine et al., Left Atrial Appendage Occlusion Study (LAAOS): Results of a Randomized Controlled Pilot Study of Left Atrial Appendage Occlusion during Coronary Bypass Surgery in Patients at Risk for Stroke, Am. heart j, vol.150, pp.288-93, 2005.

. Authors, Task Force Members et al, 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation: An Update of the 2010 ESC Guidelines for the Management of

R. Lewalter, B. Ibrahim, A. J. Albers, and . Camm, An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation, Atrial Fibrillation * Developed with the Special Contribution of the European Heart Rhythm Association, pp.1385-1413, 2012.
DOI : 10.1093/europace/eut043

T. Gordon, D. R. Holmes, and U. S. Post-approval, Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Sievert, Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation: Early Clinical Experience, J. Am. Coll. Cardiol. Circulation, vol.69, issue.105, pp.253-61, 2002.

. Reisman, Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy, JACC Cardiovasc Interv, vol.2, pp.594-600, 2009.

J. Bartorelli, P. Marco, K. H. Probst, S. H. Kuck, F. Ostermayer et al., PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for Prevention of Cardioembolic Stroke in Non-Anticoagulation Eligible Atrial Fibrillation Patients: Results from the European PLAATO Study, EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology Sick, Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomised Non-Inferiority Trial, The Lancet 374, pp.220-2610, 1016.

D. R. Belgaid, Z. Khan, M. Zaidi, and A. Hobbs, Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients with Atrial Fibrillation versus

D. R. Almany and . Holmes, Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation, J. Am. Coll. Cardiol, vol.49, pp.1490-95, 2007.

R. B. Fountain, D. R. Holmes, K. Chandrasekaran, D. Packer, S. Asirvatham et al., The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial, Variation in Anticoagulant Recommendations by the Guidelines and Decision Tools among Patients with Atrial Fibrillation, pp.956-61, 2006.
DOI : 10.1016/j.ahj.2006.02.005

S. R. Holmes, S. Doshi, M. J. Kar, J. M. Price, H. Sanchez et al., hc-sc.gc.ca/dhp-mps/prodpharma/sbd- smd/md-im/sbd-smd-2016-watchman-240876-eng.php. 113 D Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation, Summary Basis of Decision (SBD) for Watchman Left Atrial Appendage Closure Device with Delivery System, pp.2015-2614, 2017.

V. Boersma, B. Schmidt, T. R. Betts, H. Sievert, C. Tamburino et al., EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology, Implant Success and Safety of Left Atrial Appendage Closure with the WATCHMAN Device: Peri-Procedural Outcomes from the EWOLUTION Registry, pp.460-65, 2016.
DOI : 10.1016/j.jacc.2013.03.035

. Waksman, Comparison of Watchman Device with New Oral Anti-Coagulants in Patients with

A. Amulet and J. , PMID: 26716593. 119 M, pp.34-38, 2016.

A. Chan and J. Marquis, Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy, J. Am. Coll. Cardiol, vol.62, pp.96-102, 2013.

J. Kefer, P. Vermeersch, W. Budts, T. Depotter, A. Aminian et al., Transcatheter Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation with Amplatzer Cardiac Plug: The Belgian Registry, Acta cardiol, pp.551-558, 2013.

G. Pastormerlo, S. Rosso, and . Berti, Percutaneous Left Atrial Appendage Occlusion in Patients with Non-Valvular Atrial Fibrillation: Implantation and up to Four Years Follow-up of the AMPLATZER Cardiac Plug, EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, vol.11, pp.1188-94, 2016.

M. Costa, R. Ibrahim, W. Schillinger, B. Meier, and J. Park, Left Atrial Appendage Occlusion for Stroke Prevention in Atrial Fibrillation: Multicentre Experience with the AMPLATZER Cardiac Plug, Left Atrial Appendage Occlusion for Stroke Prevention, pp.1170-79

. Schmidt, M. Fastner, B. Behnes, M. Sartorius, K. Yildiz et al., Borggrefe and I. Akin, Left Atrial Appendage Morphology, Echocardiographic Characterization, Procedural Data and in-Hospital Outcome of Patients Receiving Left Atrial Appendage Occlusion Device Implantation: A Prospective Observational Study, Heart Rhythm BMC cardiovasc. disord, vol.10, issue.16, pp.1792-9910, 1186.

D. Stone, T. Byrne, and A. Pershad, Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation, Catheterization and Cardiovascular Interventions, vol.111, issue.1
DOI : 10.1016/j.amjcard.2012.11.061

. Anticoagulation, . Lariat-device-for, . Laa-exclusion, . J. Catheter, K. Lee et al., Catheter-Based Left Atrial Appendage (LAA) Ligation for the Prevention of Embolic Events Arising From the LAA: Initial Experience in a Canine Model Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial Fibrillation, Thambo, Percutaneous Left Atrial Appendage Closure Followed by Single Antiplatelet Therapy: Short-and Mid-Term Outcomes S. M. Singh, A. Micieli, and H. C. Wijeysundera, Economic Evaluation of Percutaneous Left, pp.121-148, 2010.

. Atrial-appendage-occlusion, Dabigatran, and Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation The Budget Impact of Left, Circulation, vol.127, pp.2414-2437, 2013.

L. Financement-de and L. , fr -Fédération Hospitalière de France, 2017.